- Home
- HOTH vs ALBT Comparison
HOTH vs ALBT Comparison
Compare HOTH & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- ALBT
- Stock Information
- Founded
- HOTH 2017
- ALBT 2014
- Country
- HOTH United States
- ALBT United States
- Employees
- HOTH N/A
- ALBT N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HOTH Health Care
- ALBT Health Care
- Exchange
- HOTH Nasdaq
- ALBT Nasdaq
- Market Cap
- HOTH 8.3M
- ALBT 5.3M
- IPO Year
- HOTH 2019
- ALBT N/A
- Fundamental
- Price
- HOTH $0.97
- ALBT $3.75
- Analyst Decision
- HOTH Strong Buy
- ALBT
- Analyst Count
- HOTH 3
- ALBT 0
- Target Price
- HOTH $4.00
- ALBT N/A
- AVG Volume (30 Days)
- HOTH 218.1K
- ALBT 78.9K
- Earning Date
- HOTH 05-20-2025
- ALBT 05-30-2025
- Dividend Yield
- HOTH N/A
- ALBT N/A
- EPS Growth
- HOTH N/A
- ALBT N/A
- EPS
- HOTH N/A
- ALBT N/A
- Revenue
- HOTH N/A
- ALBT $486,815.00
- Revenue This Year
- HOTH N/A
- ALBT N/A
- Revenue Next Year
- HOTH N/A
- ALBT N/A
- P/E Ratio
- HOTH N/A
- ALBT N/A
- Revenue Growth
- HOTH N/A
- ALBT N/A
- 52 Week Low
- HOTH $0.58
- ALBT $2.11
- 52 Week High
- HOTH $3.80
- ALBT $21.60
- Technical
- Relative Strength Index (RSI)
- HOTH 59.33
- ALBT 45.58
- Support Level
- HOTH $0.85
- ALBT $3.50
- Resistance Level
- HOTH $0.95
- ALBT $3.99
- Average True Range (ATR)
- HOTH 0.06
- ALBT 0.41
- MACD
- HOTH 0.02
- ALBT 0.08
- Stochastic Oscillator
- HOTH 95.42
- ALBT 48.09
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.